The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
Clinical trial NCT07010432 · RECRUITING
Trial details
- NCT number
- NCT07010432
- Sponsor
- Novo Nordisk A/S
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-12
- Primary completion
- 2028-05-03
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.